cancer risk
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
cancer risk
Jun 24, 2024, 11:48 |
Blog
Amy Byer Shainman: Attention, fellow patient advocates, genetic counselors desperately need our help
Kathy Baker, Founder and Executive Director of My Faulty Gene, shared the following post by…
Jun 14, 2024, 15:36 |
Blog
Direct Connect Partnership with Massachusetts Firefighters at Dana-Farber
Dana-Farber News made the following post on X: "Dana-Farber announces the launch of the Direct…
May 23, 2024, 05:49 |
Insight
Mert Sabuncu: In screening 'change over time' is the most important signal
Mert Sabuncu, Professor at Cornell Tech, shared on X: "In screening, e.g. for breast or…
May 22, 2024, 11:01 |
Blog
Josh Atkins: Identifying Proteomic Risk Factors
Josh Atkins, Senior Cancer Genomic Epidemiologist at the Nuffield Department of Population Health of Oxford…
May 9, 2024, 12:29 |
Insight
Fumiko Ladd Chino: Fantastic day participating in a cancer risk and control discussion
Fumiko Ladd Chino shared a post by Louis Cappelli, Radiation Oncology Resident at Thomas Jefferson…
May 7, 2024, 23:34 |
Insight
Sebastian Schmidt: Lung cancer screening in Japan
Sebastian Schmidt, Head of Strategy and Medical Affairs Computed Tomography at Siemens Healthineers, shared a…
Apr 17, 2024, 00:22 |
Insight
Jeffrey Lee: Very important work from Banu Arun, Weniy Wang and their team for developing new risk prediction models for Li-Fraumeni syndrome
Jeffrey Lee, Chief Cancer Network Officer and Deputy Chief Operating Officer at MD Anderson Cancer…
Apr 14, 2024, 12:03 |
Insight
Karen Knudsen: President Biden recently declared April National Cancer Prevention and Early Detection Month
Quoting Karen Knudsen’s post on LinkedIn: ''President Biden recently declared April as National Cancer Prevention…
Oct 1, 2023, 15:47 |
Blog
Expanding access to genetic testing and counselling for cancer risk assessment are critical steps National Cancer Program stakeholders must take. - President’s Cancer Panel
All:
9
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube